Skip to main content

What's new

LifeScan recently launched OneTouch Solutions, a platform that might save you time and money. OneTouch Solutions allows you to connect your OneTouch blood glucose meter with a variety of top-rated health services with the option of bundled subscriptions. Continue Reading »

One Drop, a digital health coaching platform providing personal care for people with chronic conditions worldwide, recently announced the release of a cardiovascular disease prevention program powered by artificial intelligence (AI). Continue Reading »

Dexcom and Garmin now offer a way to see your glucose levels and trends on your compatible Garmin smartwatch or cycling computer. Don Muchow, a seasoned extreme endurance athlete with type 1 diabetes, shares his experience with this new feature. Continue Reading »

DreaMed’s artificial intelligence platform, Advisor Pro, which can deliver insulin dosing recommendations is now FDA approved for people with diabetes on multiple daily injections therapy. Because doing the math and analysis to make manual dosing adjustments can be both time consuming and distracting, this platform can help simplify the process and get people access to quality care, remotely. Continue Reading »

Justine Szafran embarked on a decade long journey to search for diabetes technology that would deliver her insulin and track her glucose – devices that could give her the information she wanted and the simplicity she was craving. Continue Reading »

If you are currently taking three or more insulin injections per day, you may be eligible to participate in a clinical trial that provides you with the Guardian Connect continuous glucose monitor (CGM) system, InPen smart insulin pen, and smart insulin pen caps. Continue Reading »

The Tu Salud study showed that use of a OneTouch Verio Flex meter with the Spanish-language OneTouch Reveal app in an underserved Hispanic population led to sustained improvements in diabetes management. Continue Reading »

Technologies like CGM and insulin pumps have the potential to revolutionize a person’s diabetes care and management. Unfortunately, too many people with diabetes, particularly people of color and those who are low-income, do not have access to these devices.  Continue Reading »

Pages